Anemia: Considerations for the Dental Practitioner

Main Article Content

Georges Aoun
Pamela Aoun
Wissam Sharrouf
Abbass El-Outa


Anemia is a condition of decreased red blood cell number or hemoglobin concentration, or of disturbance in their function, ultimately leading to decreased oxygen transport to tissues. Many factors and diseases may lead to anemia, with wide manifestations systemically as well as orally. Therefore, a sound understanding of this condition is essential for the dental practitioner, with emphasis on alerting signs, dental management and proper communication with patient’s physician.

Anemia, dental, management, oral manifestations

Article Details

How to Cite
Aoun, G., Aoun, P., Sharrouf, W., & El-Outa, A. (2021). Anemia: Considerations for the Dental Practitioner. International Blood Research & Reviews, 12(2), 1-6.
Review Article


Turner J, Parsi M, Badireddy M. Anemia. [Updated 2020 Sep 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.


Patton LL, Glick M. The ADA practical guide to patients with medical conditions. 2nd ed. Hoboken (New Jersey): John Wiley and Sons. 2016;81-88.

Derossi SS, Raghavendra S. Anemia. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2003; 95(2):131-141.

Usuki K. [Anemia: from basic knowledge to up-to-date treatment. Topic: IV. Hemolytic anemia: Diagnosis and treatment]. Nihon Naika Gakkai Zasshi. 2015;104(7):1389-1396.

Engebretsen KV, Blom-Høgestøl IK, Hewitt S, Risstad H, Moum B, Kristinsson JA, et al. Anemia following Roux-en-Y gastric bypass for morbid obesity; A 5-year follow-up study. Scandinavian Journal of Gastroenterology. 2018;53(8):917-922.

Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therapeutic Advances in Gastroenterology. 2011;4(3):177-184.

Menaa F. Stroke in sickle cell anemia patients: A need for multidisciplinary approaches. Atherosclerosis. 2013;229(2):496–503.

Mahan LK, Raymond JL. Krause’s food & the nutrition care process. 14th ed. St Louis, Missouri: Elsevier. Chapter 32, Medical Nutrition Therapy of Anemia. 2017;631-643.

Wonkam A, Chimusa ER, Mnika K, Pule GD, Ngo Bitoungui VJ, Mulder N, et al. Genetic modifiers of long‐term survival in sickle cell anemia. Clinical and Translational Medicine. 2020;10(4):152.

Helmi N, Bashir M, Shireen A, Ahmed IM. Thalassemia review: Features, dental considerations and management. Electron Physician. 2017;9(3):4003-4008.

Karakas S, Tellioglu AM, Bilgin M, Omurlu IK, Caliskan S, Coskun S. Craniofacial characteristics of thalassemia major patients. The Eurasian Journal of Medicine. 2016;48(3):204-208.

Konda M, Godbole A, Pandey S, Sasapu A. Vitamin B12 deficiency mimicking acute leukemia. Proceedings (Baylor University Medical Center). 2019;32(4):589-592.

Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, et al. Vitamin B12 deficiency. Nature reviews. Disease Primers. 2017;3:17040.

Chan CQ, Low LL, Lee KH. Oral vitamin B12 replacement for the treatment of pernicious anemia. Frontiers in Medicine (Lausanne). 2016;3:38.

Linder L, Tamboue C, Clements JN. Drug-Induced vitamin B12 deficiency: A focus on proton pump inhibitors and histamine-2 antagonists. Journal of Pharmacy Practice. 2017;30(6):639-642.

Damião CP, Rodrigues AO, Pinheiro MF, da Cruz Filho RA, Cardoso GP, Taboada GF, et al. Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: A cross-sectional study. Sao Paulo Medical Journal. 2016;134(6):473-479.

Green R, Datta Mitra A. Megaloblastic anemias: Nutritional and other causes. The Medical Clinics of North America. 2017;101(2):297-317.

Cylwik B, Chrostek L. Zaburzenia metabolizmu kwasu foliowego i homocysteiny w warunkach naduzywania alkoholu [Disturbances of folic acid and homocysteine metabolism in alcohol abuse]. Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiegoi. 2011;30(178):295-299.

Drexler B, Zurbriggen F, Diesch T, Viollier R, Halter JP, Heim D, et al. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation. Annals of Hematology. 2020;99(11):2529-1538.

Tichelli A, de Latour RP, Passweg J, Knol-Bout C, Socié G, Marsh J, et al. SAA working party of the EBMT. Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: A severe aplastic anemia working party trial from the european group of blood and marrow transplantation. Haematologica. 2020;105(5):1223-1231.

Vaht K, Göransson M, Carlson K, Isaksson C, Lenhoff S, Sandstedt A, et al. Incidence and outcome of acquired aplastic anemia: Real-world data from patients diagnosed in Sweden from 2000-2011. Haematologica. 2017;102(10):1683-1690.

Cascio MJ, DeLoughery TG. Anemia: Evaluation and diagnostic tests. The Medical Clinics of North America. 2017;101(2):263-284.

Mulimani P, Ballas SK, Abas AB, Karanth L. Treatment of dental complications in sickle cell disease. Cochrane Database of Systematic Reviews. 2019;12(12): CD011633.

Chekroun M, Chérifi H, Fournier B, Gaultier F, Sitbon IY, Ferré FC, et al. Oral manifestations of sickle cell disease. British Dental Journal. 2019;226(1):27-31.

Soundarya N, Suganthi P. A review on anaemia – types, causes, symptoms and their treatments. Journal of science and technology investigation. 2016;1(1):10-17

McCord C, Johnson L. Oral manifestations of hematologic disease. Atlas of the Oral and Maxillofacial Surgery Clinics of North America. 2017;25(2):149-162.